Moderna (MRNA) Property, Plant & Equipment (Net) (2017 - 2026)
Powered by 
Analysis
Moderna (MRNA) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 8.55 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 5.83 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 1.67 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 5.46 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 2.06 Bn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 2.99 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | 11.32 Mn |
| 10 | Insmed | 28.06 Bn | 26.90 Bn | 358.27 Mn | 107.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.06 Bn |
| Mar 31, 2026 | 2.09 Bn |
| Dec 31, 2025 | 2.13 Bn |
| Sep 30, 2025 | 2.13 Bn |
| Jun 30, 2025 | 2.17 Bn |
| Mar 31, 2025 | 2.21 Bn |
| Dec 31, 2024 | 2.20 Bn |
| Sep 30, 2024 | 2.38 Bn |
| Jun 30, 2024 | 2.20 Bn |
| Mar 31, 2024 | 2.06 Bn |
| Dec 31, 2023 | 1.95 Bn |
| Sep 30, 2023 | 1.95 Bn |
| Jun 30, 2023 | 2.28 Bn |
| Mar 31, 2023 | 2.02 Bn |
| Dec 31, 2022 | 2.02 Bn |
| Sep 30, 2022 | 2.02 Bn |
| Jun 30, 2022 | 1.32 Bn |
| Mar 31, 2022 | 1.34 Bn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | 845.00 Mn |